BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11397964)

  • 1. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation.
    Sester M; Sester U; Gärtner B; Heine G; Girndt M; Mueller-Lantzsch N; Meyerhans A; Köhler H
    Transplantation; 2001 May; 71(9):1287-94. PubMed ID: 11397964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection.
    Sester M; Sester U; Gärtner BC; Girndt M; Meyerhans A; Köhler H
    J Am Soc Nephrol; 2002 Oct; 13(10):2577-84. PubMed ID: 12239248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation.
    Sester U; Gärtner BC; Wilkens H; Schwaab B; Wössner R; Kindermann I; Girndt M; Meyerhans A; Mueller-Lantzsch N; Schäfers HJ; Sybrecht GW; Köhler H; Sester M
    Am J Transplant; 2005 Jun; 5(6):1483-9. PubMed ID: 15888058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
    Widmann T; Sester U; Gärtner BC; Schubert J; Pfreundschuh M; Köhler H; Sester M
    PLoS One; 2008; 3(11):e3634. PubMed ID: 18982061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO; Martinez V; Buitrago A; Jiménez C; Rivas B; Escuin F; Santana MJ; Selgas R; Bellón T
    Transplantation; 2014 Apr; 97(8):839-45. PubMed ID: 24345896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation.
    Widmann T; Sester U; Schmidt T; Gärtner BC; Schubert J; Pfreundschuh M; Sester M
    Eur J Haematol; 2018 Jul; 101(1):38-47. PubMed ID: 29652096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.
    Gamadia LE; Remmerswaal EB; Weel JF; Bemelman F; van Lier RA; Ten Berge IJ
    Blood; 2003 Apr; 101(7):2686-92. PubMed ID: 12411292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune responses to cytomegalovirus in renal transplant recipients.
    Radha R; Jordan S; Puliyanda D; Bunnapradist S; Petrosyan A; Amet N; Toyoda M
    Am J Transplant; 2005 Jan; 5(1):110-7. PubMed ID: 15636618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant assessment of pp65-specific CD4 T cell responses identifies CMV-seropositive patients treated with rATG at risk of late onset infection.
    López-Oliva MO; Martínez V; Rodríguez-Sanz A; Álvarez L; Santana MJ; Selgas R; Jiménez C; Bellón T
    Clin Immunol; 2020 Feb; 211():108329. PubMed ID: 31891764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of CD4(+) T cells in human cytomegalovirus infection.
    Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
    Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.
    Martín-Gandul C; Pérez-Romero P; Mena-Romo D; Molina-Ortega A; González-Roncero FM; Suñer M; Bernal G; Cordero E;
    Transpl Infect Dis; 2018 Jun; 20(3):e12883. PubMed ID: 29570917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE; Halliday D; Lawton N; Wang H; Abdalla I; Masters J; Hassan RL; Hart IJ; Khan N; Smith J; Hammad A; Bakran A
    Transpl Immunol; 2009 Dec; 22(1-2):99-104. PubMed ID: 19635559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
    Sund F; Lidehäll AK; Claesson K; Foss A; Tötterman TH; Korsgren O; Eriksson BM
    Clin Transplant; 2010; 24(3):401-9. PubMed ID: 19222507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.
    McGoldrick SM; Bleakley ME; Guerrero A; Turtle CJ; Yamamoto TN; Pereira SE; Delaney CS; Riddell SR
    Blood; 2013 Apr; 121(14):2796-803. PubMed ID: 23412093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia.
    Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH
    Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients.
    Egli A; Silva M; O'Shea D; Wilson LE; Baluch A; Lisboa LF; Hidalgo LG; Kumar D; Humar A
    PLoS One; 2012; 7(11):e43937. PubMed ID: 23071829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus.
    Stone SF; Price P; Khan N; Moss PA; French MA
    AIDS; 2005 Mar; 19(6):555-62. PubMed ID: 15802973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.